醫療用聚合物的全球市場:現狀分析與預測(2021年~2027年)
市場調查報告書
商品編碼
1122986

醫療用聚合物的全球市場:現狀分析與預測(2021年~2027年)

Medical Polymer Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 263 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球醫療用聚合物的市場規模在預測期間(2021年~2027年)中預計將以約8%的年複合成長率成長。人口老齡化的增加、傳染病的流行以及需要復雜手術治療的心血管疾病的流行正在推動醫用聚合物市場的增長。

本報告提供全球醫療用聚合物市場的相關調查,提供市場洞察,市場趨勢,競爭模式,企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 限制
  • 相關利益者
  • 報告所使用的貨幣

第2章 調查方法或假設

  • 醫療用聚合物市場調查流程
  • 醫療用聚合物市場調查手法
  • 預測方法
  • 受訪者簡介
  • 醫療用聚合物市場調查的主要目的

第3章 市場摘要

第4章 摘要整理

第5章 全球醫療用聚合物市場上COVID-19的影響

第6章 全球醫療用聚合物市場收益(100萬美元)(2019年~2027年)

第7章 市場洞察:各類型

  • 產品聚合物
  • 工程塑膠
  • 高性能聚合物

第8章 市場洞察:各組成

  • 結晶質
  • 非結晶質

第9章 市場洞察:各用途

  • 醫療用拋棄式用品
  • 補綴
  • 醫療設備及工具
  • 藥物輸送
  • 其他

第10章 市場洞察:各地區

  • 北美的醫療用聚合物市場
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲的醫療用聚合物市場
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區的醫療用聚合物市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他亞太地區
  • 其他的全球醫療用聚合物市場

第11章 醫療用聚合物市場力學

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 醫療用聚合物市場機會

第13章 醫療用聚合物市場趨勢

第14章 法律及法律規範

第15章 需求面和供給面的分析

  • 需求面分析
  • 供給面分析
    • 主要產品的銷售
    • 主要企業夥伴關係
    • 前幾名的事業擴大,投資,出售
    • 主要的合併和收購

第16章 價值鏈分析

第17章 競爭模式

  • 波特的五力分析
    • 買方議價能力
    • 供應商談判力
    • 競爭的激烈程度
    • 新加入廠商者的威脅
    • 替代品的威脅
  • 企業佔有率分析:各收益

第18章 公司概要

  • SABIC
  • BASF SE
  • Celanese Corporation
  • Evonik Industries AG
  • Solvay S.A.
  • Arkema S.A.
  • The Lubrizol Corporation
  • The Ensinger Group
  • Covestro AG
  • Victrex plc

第19章 免責聲明

簡介目錄
Product Code: UMCH211094

The global medical polymer market is likely to showcase a growth of around 8% during the forecast period. Today, the aging population is rapidly growing all over the world and around two-thirds of cancer occurs mainly in people who are 65 years old or above. With aging, the physiological functions of the body get affected such as impairment of vision and hearing, reduced gastrointestinal motility, kidney function, and reduced cardiovascular function. The rise in the geriatric population coupled with overspreading of infectious diseases, and the rising prevalence of cancer, arthritis, and cardiovascular diseases, which require complex surgical treatments propel the medical polymer market growth. In addition, now, countries are focusing more on improving the healthcare sector, which in turn is likely to fuel the market.

Insights Presented in the Report

"Amongst type, the high-performance polymer segment is likely to showcase substantial growth during the forecast period"

Based on type, the market is categorized into commodity polymer, engineering polymer, and high-performance polymer. Among these, the high-performance polymer is likely to showcase robust growth owing to the increasing adoption of these polymers in prosthetics, medical devices, and drug delivery devices applications due to their resilience against a majority of body substances and are highly heat resistant and inert, thereby which makes them ideal for medical devices that come into direct contact with blood and tissue. 

"Amongst applications, medical disposable segment held a prominent share in the market in 2020"

Based on application, the market is categorized into medical disposables, prosthetics, medical instruments & tools, drug delivery, and others. Among these, medical disposables accounted for a significant share of the market and is likely to showcase considerable growth during the forecast period. Medical disposables are single-use products that are prerequisite supplies before any surgery or procedure. As the cases of chronic diseases are increasing, demand for surgery and other procedure will eventually grow. Thereby, increasing the demand for medical disposables. Further, changing lifestyles of people, demand for better healthcare services, and the growing geriatric population are also contributing to the segment growth.

"North America accounted for a considerable share in the global medical polymer market"

For a better understanding of the market adoption of Medical Polymer, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America accounted for a prominent share in the medical polymer market on account of the presence of a highly diversified medical devices market and it offers a wide range of products for the diagnosis and treatment of patients, ranging from medical catheters to implants and vascular grafts.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive country-level analysis of the industry

Customization Options:

The global medical polymer market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Medical Polymer Market
  • 2.2. Research Methodology of the Medical Polymer Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Medical Polymer Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL MEDICAL POLYMER MARKET COVID-19 IMPACT

6 GLOBAL MEDICAL POLYMER MARKET REVENUE (USD MN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Commodity Polymer
  • 7.2. Engineering Polymer
  • 7.3. High-Performance Polymer

8 MARKET INSIGHTS BY STRUCTURE

  • 8.1. Crystalline
  • 8.2. Amorphous

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Medical Disposables
  • 9.2. Prosthetics
  • 9.3. Medical Instruments & Tools
  • 9.4. Drug Delivery
  • 9.5. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Medical Polymer Market
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Medical Polymer Market
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. United Kingdom
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia Pacific Medical Polymer Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Rest of World Medical Polymer Market

11 MEDICAL POLYMER MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 MEDICAL POLYMER MARKET OPPORTUNITIES

13 MEDICAL POLYMER MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis
    • 15.2.1. Top Product Launches
    • 15.2.2. Top Business Partnerships
    • 15.2.3. Top Business Expansions, Investments, and Divestitures
    • 15.2.4. Top Merger and Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Porters Fiver Forces Analysis
    • 17.1.1. Bargaining Power of Buyer
    • 17.1.2. Bargaining Power of Supplier
    • 17.1.3. Intensity of Rivalry
    • 17.1.4. Threats of New Entrant
    • 17.1.5. Threat of Substitute
  • 17.2. Company Share Analysis, by Revenue

18 COMPANY PROFILED

  • 18.1. SABIC
  • 18.2. BASF SE
  • 18.3. Celanese Corporation
  • 18.4. Evonik Industries AG
  • 18.5. Solvay S.A.
  • 18.6. Arkema S.A.
  • 18.7. The Lubrizol Corporation
  • 18.8. The Ensinger Group
  • 18.9. Covestro AG
  • 18.10. Victrex plc

19 DISCLAIMER